| Product NDC: | 0338-3993 | 
| Proprietary Name: | IFEX | 
| Non Proprietary Name: | ifosfamide | 
| Active Ingredient(s): | 3 g/1 & nbsp; ifosfamide | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0338-3993 | 
| Labeler Name: | BAXTER HEALTHCARE CORPORATION | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA019763 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20120301 | 
| Package NDC: | 0338-3993-01 | 
| Package Description: | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0338-3993-01) | 
| NDC Code | 0338-3993-01 | 
| Proprietary Name | IFEX | 
| Package Description | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0338-3993-01) | 
| Product NDC | 0338-3993 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | ifosfamide | 
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20120301 | 
| Marketing Category Name | NDA | 
| Labeler Name | BAXTER HEALTHCARE CORPORATION | 
| Substance Name | IFOSFAMIDE | 
| Strength Number | 3 | 
| Strength Unit | g/1 | 
| Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |